Acthar Gel 80 UNT/ML Injectable Solution

DRUG3 trials

Sponsors

Rhode Island Hospital, NephroNet, Inc., Toyos Clinic

Conditions

Autoimmune DiseasesDry EyeFibrillary GlomerulonephritisNeurotrophic KeratitisSteroid-Resistant Nephrotic Syndrome

Phase 4

ACTHAR Gel for Drug REsistant Nephrotic Syndrome in Children

WithdrawnNCT03408405

Rhode Island HospitalSteroid-Resistant Nephrotic Syndrome

Start: 2018-06-30End: 2021-07-31Updated: 2019-04-23

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

NephroNet, Inc.Fibrillary Glomerulonephritis

Start: 2019-03-14End: 2024-10-27Target: 34Updated: 2022-10-31

Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease

RecruitingNCT06964269

Toyos ClinicAutoimmune Diseases, Dry Eye, Neurotrophic Keratitis

Start: 2025-02-11End: 2028-02-28Target: 20Updated: 2025-05-11